Table 2.
Arm | Total, No. | PR | CR | OR, No. of Patients (%) | ||
---|---|---|---|---|---|---|
No. of Patients (%) | Duration of Response, Months | No. of Patients (%) | Duration of Response, Months | |||
NMA | 51 | 11 (22) | 51+, 43+, 38+, 37+, 29+, 21, 19, 17, 6, 4, 4 | 12 (24) | 48+, 45+, 44+, 42+, 42+, 42+, 42+, 41+, 40+, 39+, 36+, 32+ | 23 (45) |
1,200 TBI | 50 | 19 (38) | 51+, 50+, 40+, 25, 19*+, 14, 13, 11, 11, 10, 9, 9, 9, 9, 8, 6, 5, 5, 4 | 12 (24) | 53+, 46+, 45+,42+, 42+, 38*+, 37+, 36+, 27,27+, 25+, 14*+ | 31 (62) |
Total | 101† | 30 (30) | 24 (24) | 54 (54); P = .11 |
Abbreviations: +, ongoing response; CR, complete response; NMA, nonmyeloablative chemotherapy; OR, objective response; PR, partial response; TBI, total body irradiation.
Death with no evidence of progression.
An additional 10 patients underwent resection with intent to treat.